Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes
Introduction The prevalence and incidence of autoimmune diseases are rising rapidly, recording approximately 19.1% increase of incidences annually, which poses a substantial global health challenge.1 Autoimmune diseases, caused by the breakdown of self- …